Pharsight

Drugs that contain Tobramycin

1. Bethkis patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7939502 CHIESI Optimised formulation of tobramycin for aerosolization
Jun, 2022

(1 year, 8 months ago)

US6987094 CHIESI Optimized formulation of tobramycin for aerosolization
Sep, 2022

(1 year, 5 months ago)

US7696178 CHIESI Optimised formulation of tobramycin for aerosolization
Sep, 2022

(1 year, 5 months ago)

Market Authorisation Date: 12 October, 2012

Treatment: Management of cystic fibrosis patients

Dosage: SOLUTION;INHALATION

How can I launch a generic of BETHKIS before it's drug patent expiration?
More Information on Dosage

BETHKIS family patents

Family Patents

2. Tobi Podhaler patents expiration

TOBI PODHALER's oppositions filed in EPO
TOBI PODHALER Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7368102 MYLAN SPECIALITY LP Pulmonary delivery of aminoglycosides
Dec, 2022

(1 year, 2 months ago)

US8715623 MYLAN SPECIALITY LP Pulmonary delivery of aminoglycoside
Dec, 2022

(1 year, 2 months ago)

US9421166 MYLAN SPECIALITY LP Pulmonary delivery of aminoglycoside
Dec, 2022

(1 year, 2 months ago)

US7516741 MYLAN SPECIALITY LP Aerosolization apparatus with feedback mechanism
Jan, 2024

(a month ago)

USRE47526 MYLAN SPECIALITY LP Aerosolization apparatus with air inlet shield
Apr, 2024

(a month from now)

US8069851 MYLAN SPECIALITY LP Aeorosolization apparatus with air inlet shield
Sep, 2024

(6 months from now)

US11484671 MYLAN SPECIALITY LP Aerosolization apparatus with capsule puncture alignment guide
Nov, 2024

(8 months from now)

US8664187 MYLAN SPECIALITY LP Methods of treatment of endobronchial infections
Jun, 2025

(1 year, 3 months from now)

US7559325 MYLAN SPECIALITY LP Aerosolization apparatus with air inlet shield
Oct, 2025

(1 year, 8 months from now)

US8869794 MYLAN SPECIALITY LP Aerosolization apparatus with capsule puncturing member
Sep, 2028

(4 years from now)

US10207066 MYLAN SPECIALITY LP Aerosolization apparatus with capsule puncture alignment guide
Nov, 2030

(6 years from now)

Market Authorisation Date: 22 March, 2013

Treatment: Treatment of cystic fibrosis patients with pseudomonas aeruginosa

Dosage: POWDER;INHALATION

More Information on Dosage

TOBI PODHALER family patents

Family Patents